Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.
     



Asthma and chronic obstructive pulmonary disease: which drugs?

                                                                                                                              

Chronic respiratory diseases, in particular asthma and COPD (chronic obstructive pulmonary disease), are among the main causes of morbidity and mortality, and a growing trend is predicted for the coming years. The data provided by the World Health Organisation estimate that there are currently hundreds of millions of people suffer from chronic respiratory diseases:

  • approximately 300 million have asthma;
  • 80 million suffer from moderate to severe degree COPD;
  • another million suffer from the consequences of mild COPDs, allergic rhinitis and other chronic respiratory diseases.

What therapies are used with these patients?  Trying to answer this question will be the international symposium entitled “Pharmacology and therapeutics of bronchodilators” to be held from 19 to 21 October in Palazzo Brancaccio, Viale del Monte Oppio 7, Rome, organised by the Tor Vergata University of Rome and promoted by the Fondazione Internazionale Menarini.

Initially used to reduce the symptoms of respiratory disease, bronchodilators have benefited from scientific research and are now considered an essential element in the treatment of these diseases. During the symposium, Italian and international experts will describe the pharmacology of bronchodilators, discussing when to use a long-acting or fast-acting drug, at what dosage and how frequently, the relationship between bronchodilators and physical exercise, without forgetting the problem of doping in athletes, the use of these drugs in the elderly and the effects of bronchodilators on the cardiovascular system.

 



PRESIDENT OF THE MEETING:

Mario Cazzola
University of Rome Tor Vergata

Paola Rogliani
University of Rome Tor Vergata

Reserved area

Press Release:
Nobel Prize recipient Louis Ignarro

Minuti Menarini Online

Beside the Scientific Edition, Fondazione Menarini edits the publication of the Artistic Edition of "Minuti Menarini" addressed to all Italian doctors who love art



Fondazione Internazionale Menarini

SIGN UP FOR THE NEWSLETTER

Receive information about the Fondazione Internazionale Menarini every month.

Sign Up

Fondazione Internazionale Menarini
Fondazione Menarini, Centro Direzionale Milanofiori 20089 Rozzano (MI) - Edificio L - Strada 6
Tel. +39 02 55308110 Fax +39 02 55305739 C.F. 94265730484